Once touted as a close rival to Meta Platforms' Instagram, the relatively small social media company remains unp ...

You want to sign up for Social Security at the right time so you get the most money possible, but it's not always easy to ...

Methanex supplies methanol worldwide, using integrated operations and its own fleet to serve industrial clients across major ...

Maze Therapeutics is a U.S. biotech advancing clinical-stage precision medicines for renal and metabolic diseases.

This clinical-stage biotech targets RAS/MAPK pathway cancers with a pipeline of novel small molecule oncology therapies.

Tyra Biosciences develops targeted therapies for cancer and rare diseases, leveraging proprietary technology to advance its ...

Viridian Therapeutics develops monoclonal antibody therapies targeting serious diseases, with a primary focus on thyroid eye ...

Alumis develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases through proprietary TYK2 ...

Palantir remains a high-variance AI infrastructure bet where narrative and execution will matter equally over the next decade ...

Ares Capital's core earnings dipped in the first quarter to $0.47 per share, down from $0.50 per share in the fourth quarter ...

Same-store sales shine again. In what has been a very uneven consumer environment, Dutch Bros once again found a way to shine. Its same-store sales surged by 8.3% in the quarter, ...

This clinical-stage biotech develops antibody therapies for severe autoimmune diseases, targeting rare neuromuscular ...